Clearbridge Investments LLC raised its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 19.6% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 326,886 shares of the company's stock after acquiring an additional 53,547 shares during the quarter. Clearbridge Investments LLC owned approximately 0.35% of Acadia Healthcare worth $12,961,000 as of its most recent SEC filing.
Other hedge funds also recently modified their holdings of the company. Lindbrook Capital LLC boosted its holdings in Acadia Healthcare by 1,342.0% in the fourth quarter. Lindbrook Capital LLC now owns 721 shares of the company's stock valued at $29,000 after acquiring an additional 671 shares during the last quarter. Blue Trust Inc. lifted its position in shares of Acadia Healthcare by 69.4% in the 4th quarter. Blue Trust Inc. now owns 842 shares of the company's stock worth $33,000 after purchasing an additional 345 shares during the period. Nisa Investment Advisors LLC boosted its stake in shares of Acadia Healthcare by 40.7% in the 4th quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company's stock valued at $41,000 after purchasing an additional 301 shares during the last quarter. Signaturefd LLC increased its position in shares of Acadia Healthcare by 460.6% during the fourth quarter. Signaturefd LLC now owns 1,222 shares of the company's stock worth $48,000 after buying an additional 1,004 shares during the period. Finally, Fifth Third Bancorp raised its stake in Acadia Healthcare by 56.0% during the fourth quarter. Fifth Third Bancorp now owns 1,264 shares of the company's stock worth $50,000 after buying an additional 454 shares during the last quarter.
Wall Street Analysts Forecast Growth
A number of brokerages have weighed in on ACHC. Barclays downgraded Acadia Healthcare from an "overweight" rating to an "equal weight" rating and decreased their price target for the stock from $43.00 to $35.00 in a report on Friday, February 28th. Cantor Fitzgerald reissued a "neutral" rating and issued a $52.00 price target on shares of Acadia Healthcare in a research note on Tuesday, December 10th. StockNews.com downgraded shares of Acadia Healthcare from a "hold" rating to a "sell" rating in a research report on Monday, January 6th. Mizuho dropped their target price on shares of Acadia Healthcare from $48.00 to $37.00 and set a "neutral" rating on the stock in a research report on Tuesday, March 25th. Finally, KeyCorp reduced their price target on shares of Acadia Healthcare from $70.00 to $65.00 and set an "overweight" rating for the company in a report on Monday, March 3rd. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and five have assigned a buy rating to the company. According to MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $52.19.
Get Our Latest Stock Report on Acadia Healthcare
Acadia Healthcare Stock Down 3.5 %
ACHC traded down $0.95 during trading on Monday, hitting $26.42. 2,556,380 shares of the company's stock were exchanged, compared to its average volume of 1,427,161. The stock has a market cap of $2.45 billion, a P/E ratio of 8.66, a PEG ratio of 1.46 and a beta of 1.13. The business's 50 day moving average is $35.26 and its two-hundred day moving average is $42.75. Acadia Healthcare Company, Inc. has a fifty-two week low of $25.41 and a fifty-two week high of $82.41. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60.
Acadia Healthcare Company Profile
(
Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
See Also

Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.